Business Context and Reporting Period
This Form 8-K, dated May 23, 2026, reports material events for Bleichroeder Acquisition Corp. II (BBCQ), a Cayman Islands exempted company and emerging growth company. The filing details amendments to the proposed business combination with Pasqal Holding SAS, a French quantum computing company. Key events occurred on May 23, 2026, and May 26, 2026, involving structural changes to the merger agreement and an increase in committed financing.
Key Financial Metrics and Transaction Details
The filing does not provide standard operating financial metrics (revenue, profit, cash flow) for the reporting period as it focuses on transactional updates. However, it discloses specific financing figures:
- Increased Financing Commitment: The subscription price under the Securities Purchase Agreement (SPA) was increased by $50.0 million, bringing the total aggregate to $250.0 million.
- Instrument Details: The $250.0 million commitment is for the purchase of $312,500,000 aggregate principal amount of Senior Unsecured Convertible Bonds and related Investment Warrants.
- New Investor: An additional accredited investor advised by Inflection Point Asset Management LLC joined as a "New Purchaser" under the amended SPA.
Material Changes Versus Prior Period
Significant structural and financial modifications were made to the original February 28, 2026, Merger Agreement and March 4, 2026, Securities Purchase Agreement:
- Merger Structure Amendment: On May 26, 2026, the original "Parent Merger Sub" (Bleichroeder Acquisition 2 France) assigned its rights and obligations to a new entity, "New Merger Sub" (Bleichroeder Acquisition France Merger Sub 2). This change reflects updated reincorporation and merger mechanics.
- Financing Expansion: The SPA was amended on May 23, 2026, to increase the total capital commitment by $50.0 million and to include a new purchaser.
- Regulatory Filing: A registration statement on Form F-4 was filed with the SEC on May 26, 2026, to solicit shareholder approval for the business combination.
Guidance, Outlook, Risks, and Contingencies
The filing contains extensive forward-looking statements regarding the proposed business combination. Management highlights several critical risks and contingencies:
- Transaction Completion Risks: The deal is contingent on shareholder approval, regulatory approvals, and the absence of termination events. There is a risk that redemption requests by Bleichroeder shareholders could leave the combined company with insufficient cash.
- Operational and Market Risks: Pasqal faces risks related to emerging quantum technology, including technical challenges, commercialization delays, and market acceptance. The company also has a limited operating history and dependence on government contracts.
- Capital Requirements: There is a risk that the combined company may need additional future financing on terms that may not be favorable or available.
- Listing Risks: Uncertainty exists regarding the ability to maintain U.S. exchange listing or achieve a dual listing on Euronext Paris post-combination.
Investor Verification Checklist
- Verify the final terms of the Amendment No. 1 to the Merger Agreement (Exhibit 2.1) to confirm the specific reincorporation mechanics and the role of the new French merger subsidiary.
- Review the Amendment No. 1 to the Securities Purchase Agreement (Exhibit 10.1) to confirm the identity of the new purchaser and the specific terms of the $312.5 million convertible bonds.
- Monitor the status of the Form F-4 Registration Statement filed on May 26, 2026, for the definitive proxy statement/prospectus containing full financial data for Pasqal.
- Assess the potential impact of shareholder redemptions on the post-merger liquidity of the combined entity, as highlighted in the risk factors.
- Confirm the timeline for regulatory approvals required for the cross-border transaction between the Cayman Islands, France, and the U.S.